Current Prostate Reports

, Volume 7, Issue 2, pp 79–84 | Cite as

Nonpharmacological approaches for the treatment of urological chronic pelvic pain syndromes in men

Article
First Online:
  • 22 Downloads

Abstract

Chronic nonbacterial prostatitis, or urological chronic pelvic pain syndrome (UCPPS), remains a common and often challenging disorder to evaluate and treat. Employing a more holistic approach, including urological therapy, physical therapy, and psychosocial perspectives, may be more appropriate for most patients. Growing evidence supports the use of biofeedback, myofascial trigger point release, prescribed exercise regimens, relaxation techniques, and supportive counseling to treat men with UCPPS.

Keywords

Prostatitis Trigger Point Interstitial Cystitis Chronic Prostatitis Alfuzosin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al.: The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999, 2:369–375.Google Scholar
  2. 2.
    Shoskes DA, Landis JR, Wang Y, et al.: Impact of post-ejaculatory pain in men with category III chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:542–547.PubMedCrossRefGoogle Scholar
  3. 3.
    Sadeghi-Nejad H, Seftel A: Sexual dysfunction and prostatitis. Curr Urol Rep 2006, 7:479–484.PubMedCrossRefGoogle Scholar
  4. 4.
    Collins MM, Stafford RS, O’Leary MP, Barry MJ: How common is prostatitis? A national survey of physician visits. J Urol 1998, 159:1224–1228.PubMedCrossRefGoogle Scholar
  5. 5.
    Krieger JN, Lee SW, Jeon J, et al.: Epidemiology of prostatitis. Int J Antimicrob Agents 2008, 31(Suppl 1):S85–S90.PubMedCrossRefGoogle Scholar
  6. 6.
    Aoki Y, Kao PN: Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. Antimicrob Agents Chemother 1999, 43:2678–2684.PubMedGoogle Scholar
  7. 7.
    Galley HF, Nelson SJ, Dubbels AM, Webster NR: Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis. Crit Care Med 1997, 25:1392–1395.PubMedCrossRefGoogle Scholar
  8. 8.
    Mishra VC, Browne J, Emberton M: Role of alpha-blockers in type III prostatitis: a systematic review of the literature. J Urol 2007, 177:25–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Nickel JC, Krieger JN, McNaughton-Collins M, et al.: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 2008, 359:2663–2673.PubMedCrossRefGoogle Scholar
  10. 10.
    Nickel JC, Downey J, Pontari MA, et al.: A randomized placebo-controlled multicenter study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004, 93:991–995.PubMedCrossRefGoogle Scholar
  11. 11.
    Kaplan SA, Volpe MA, Te AE: A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol 2004, 171:284–288.PubMedCrossRefGoogle Scholar
  12. 12.
    Prahalada S, Tarantal AF, Harris GS, et al.: Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology 1997, 55:119–131.PubMedCrossRefGoogle Scholar
  13. 13.
    Nickel JC, Downie J, Arden D: Failure of a monotherapy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004, 172:551–554.PubMedCrossRefGoogle Scholar
  14. 14.
    Clemens JQ, Nadler RB, Schaeffer AJ, et al.: Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 2000, 56:951–955.PubMedCrossRefGoogle Scholar
  15. 15.
    Cornel EB, van Haarst EP, Schaarsberg RW, Geels J: The effect of biofeedback physical therapy in men with chronic pelvic pain syndrome type III. Euro Urol 2005, 47:607–611.CrossRefGoogle Scholar
  16. 16.
    Weiss JM: Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 2001, 166:2226–2231.PubMedCrossRefGoogle Scholar
  17. 17.
    Anderson RU, Wise D, Sawyer T, Chan C: Integration of myofascial trigger point release and paradoxical relation training treatment of chronic pelvic pain in men. J Urol 2005, 174:155–160.PubMedCrossRefGoogle Scholar
  18. 18.
    Fitzgerald M, Anderson R, Potts J, et al.: UPPCRN: Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urologic chronic pelvic pain syndromes. J Urol 2009 Jun 15 (Epub ahead of print).Google Scholar
  19. 19.
    Benjamin PJ, Tappan FM: Tappan’s Handbook of Healing Massage Techniques: Classic, Holistic, and Emerging Methods. Upper Saddle River, NJ: Pearson Education, Inc.; 2005.Google Scholar
  20. 20.
    Potts J: Physical therapy for CP/CPPS. In Prostatitis. Edited by Shoskes DA. New York: Humana Press; 2008.Google Scholar
  21. 21.
    Travell JG, Simons DG: Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore: Williams and Wilkins; 1983.Google Scholar
  22. 22.
    Potts JM, O’Dougherty E: Pelvic floor physical therapy for patients with prostatitis. Cur Urol Rep 2000, 1:155–158.CrossRefGoogle Scholar
  23. 23.
    Kotarinos RK: CP/CPPS Pelvic Floor Dysfunction: Evaluation and Treatment. New York: Humana Press; 2007.Google Scholar
  24. 24.
    Berghuis JP, Heiman JR, Rothman I, Berger RE: Psychological and physical factors involved in chronic idiopathic prostatitis. J Psychosom Res 1996, 41:313–325.PubMedCrossRefGoogle Scholar
  25. 25.
    Mehik A, Hellstrom P, Sarpola A, et al.: Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int 2001, 88:35–38.PubMedCrossRefGoogle Scholar
  26. 26.
    Clemens JQ, Brown SO, Calhoun EA: Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol 2008, 180:1378–1382.PubMedCrossRefGoogle Scholar
  27. 27.
    Tripp DA, Nickel JC, Wang Y, et al.: Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain 2006, 7:697–708.PubMedCrossRefGoogle Scholar
  28. 28.
    Ullrich PM, Turner JA, Ciol M, Berger R: Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis/pelvic pain. Ann Behav Med 2005, 30:112–118.PubMedCrossRefGoogle Scholar
  29. 29.
    Anderson RU, Orenberg EK, Chan CA, et al.: Psychometric profiles and hypothalamic-pituitary-adrenal axis function in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol 2008, 179:956–960.PubMedCrossRefGoogle Scholar
  30. 30.
    Wise D, Anderson R: A Headache in the Pelvis. Occidental, CA: National Center for Pelvic Pain Research; 2003.Google Scholar
  31. 31.
    Miller HC: Stress prostatitis. Urology 1988, 32:507–510.PubMedCrossRefGoogle Scholar
  32. 32.
    Kellner R: Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom 1994, 61:4–24.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Pepper PikeUSA

Personalised recommendations